The table below shows DarioHealth Corp.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$25.94M
-$38.56M
-$30.38M
-$47.84M
-$50.41M
-$17.74M
Capital expenditure
$142.00K
$138.00K
$584.00K
$442.00K
$261.00K
$118.00K
Investing cash flow
-$4.34M
-$8.93M
-$547.00K
-$573.00K
-$8.13M
-$1.62M
Dividends paid
-
-
-
-
DRIO operating cash flow (10-K history)
DarioHealth Corp. reported operating cash flow of -$25.94M for fiscal year 2025. That is up 32.7% from -$38.56M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$8.38M (FY 2016) to -$25.94M. Figures come from the company's audited annual reports as filed with the SEC.